30+ years of experience in biopharma pricing, value and access decision making and related market analyses. Global pricing an access leader in Wyeth, Eli Lilly and BMS. Consulting group leadership at Cambridge Pharma (now IQVIA) and ZS Associates. Hands-on local commercial leadership experience in the United States and Europe.
Author of "The Price of Global Health" (3rd edition, 2020), a unique reference book, which has been endorsed by industry, payers and academia and is recognized by many as the "Bible of Drug Pricing."
Columnist for Pharmaceutical Commerce.
Authored and quoted in many articles including in WSJ, NYT, Die Welt, STAT, Pharmaceutical Executive, Pharmaceutical Commerce, Clinical Therapeutics, PM360, In Vivo.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.